comparison of standard dose of human chorionic gonadotropin and human chorionic gonadotropin In combination with gonadotropin releasing hormone in IVF/ICSI cycles
Phase 4
- Conditions
- infertility.Female infertility
- Registration Number
- IRCT20101227005485N7
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
women who are candidate of IVF/ICSI and have some risk of OHSS will be entered in the study.
Exclusion Criteria
every body who have diminished ovarian reserve. (AFC<4 or AMH<1)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber and quality of resulted oocytes. Timepoint: the day of oocytes pick up. Method of measurement: microscopic evaluation.;Fertilization rate. Timepoint: 24 hours after intra-cytoplasmic sperm injection. Method of measurement: microscope.;Implantation rate. Timepoint: 2 weeks after embryo transfer. Method of measurement: Measurement of beta-hCG.;Number and quality of embryos. Timepoint: after 24 hours, day 3 and day 5. Method of measurement: microscopic evaluation.
- Secondary Outcome Measures
Name Time Method Ovarian hyperstimulation syndrome. Timepoint: the day of oocyte pick-up and a week later. Method of measurement: history, physical examination and laboratory tests.